XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Accounts Receivable and Notes Receivable
 6 Months Ended
Jun. 30, 2022
Receivables [Abstract]  
Accounts Receivable and Notes Receivable Accounts Receivable and Notes Receivable
The Company’s accounts receivable consists primarily of amounts due from third-party payors and patients. See Note 2 for a summary of the Company’s policies relating to accounts receivable.
Accounts Receivable as of June 30, 2022 and December 31, 2021 consist of the following:
(in thousands)June 30, 2022December 31, 2021
Oral drug accounts receivable$2,933 $2,097 
Capitated accounts receivable518 665
FFS accounts receivable19,985 12,530
Clinical trials accounts receivable2,029 1,823
Other trade receivables3,482 2,892
Total$28,947 $20,007 
During the three and six months ended June 30, 2022, the Company had net reversals of bad debt recoveries of $105 and $82, respectively and bad debt expense of $0, and $177, respectively. Bad debt write-offs were a result of accounts receivable on completed contracts that were deemed uncollectible during the period due to delayed collection efforts. During the three and six months ended June 30, 2021, the Company had bad debt recoveries of $722. There was no bad debt expense recognized during the three and six months ended June 30, 2021.